中文 | English
Return
Total: 140 , 1/14
Show Home Prev Next End page: GO
MeSH:(Organoplatinum Compounds/therapeutic use*)

2.Second Line Chemotherapy for Pancreatic Cancer.

Jeong Youp PARK

The Korean Journal of Gastroenterology 2011;57(4):207-212

3.Chinese expert consensus on the clinical application of the Chinese modified triplet combination with irinotecan, oxaliplatin and continuous infusional 5-fluorouracil/leucovorin for colorectal cancer.

Chinese Journal of Gastrointestinal Surgery 2021;24(6):473-479

4.Expression of CD133 in rectal cancer tissues and its relationship with neoadjuvant chemoradiotherapy.

Dongmei LI ; Huanwen WU ; Ruie FENG ; Dingrong ZHONG ; Yufeng LUO ; Yi XIAO

Chinese Journal of Gastrointestinal Surgery 2016;19(6):690-694

5.Irinotecan or oxaliplatin combined with 5-fluorouracil and leucovorin as first-line therapy for advanced colorectal cancer: a meta-analysis.

Xiao-Bo LIANG ; Sheng-Huai HOU ; Yao-Ping LI ; Li-Chun WANG ; Xin ZHANG ; Jun YANG

Chinese Medical Journal 2010;123(22):3314-3318

6.Effect of Shenqi Fuzheng injection combined with chemotherapy in treating advanced colorectal carcinoma.

Qi-Lian LIANG ; Da-Chao PAN ; Jie-Rong XIE

Chinese Journal of Integrated Traditional and Western Medicine 2009;29(5):439-441

7.Advances in new chemotherapeutic drugs for preoperative chemoradiation of locally advanced rectal cancer.

Lin XIAO ; Yuanhong GAO ; Mengzhong LIU

Chinese Journal of Gastrointestinal Surgery 2014;17(1):93-97

8.Immune enhancing effect of modified sijunzi decoction on patients with colorectal cancer undergoing chemotherapy.

Han XIAO ; Jin YANG

Chinese Journal of Integrated Traditional and Western Medicine 2011;31(2):164-167

10.Properties of the Measures to Assess Oxaliplatin-induced Peripheral Neuropathy: A Literature Review.

Sang Hui CHU ; Yoon Ju LEE ; Young Joo LEE ; Charles S CLEELAND

Journal of Korean Academy of Nursing 2015;45(6):783-801

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 140 , 1/14 Show Home Prev Next End page: GO